Celcuity (NASDAQ:CELC – Get Free Report) is projected to release its earnings data before the market opens on Wednesday, March 26th. Analysts expect Celcuity to post earnings of ($0.72) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Celcuity Trading Up 3.2 %
NASDAQ CELC opened at $10.84 on Tuesday. The company has a current ratio of 10.35, a quick ratio of 10.36 and a debt-to-equity ratio of 0.65. The business has a fifty day simple moving average of $11.24 and a 200 day simple moving average of $13.08. Celcuity has a 12 month low of $8.53 and a 12 month high of $22.19. The firm has a market capitalization of $402.49 million, a P/E ratio of -4.15 and a beta of 0.65.
Analysts Set New Price Targets
Separately, Needham & Company LLC increased their target price on shares of Celcuity from $23.00 to $29.00 and gave the company a “buy” rating in a report on Thursday, February 6th. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $30.17.
About Celcuity
Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.
Read More
- Five stocks we like better than Celcuity
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- What Investors Need to Know About Upcoming IPOs
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- 3 Stocks to Consider Buying in October
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.